State of the art and research, technologically advanced assessment and treatment.
Increasingly, the use of neuroscience technology has allowed for improved understanding of complex conditions and insufficient response to treatment.
The Qeeg provides a 3D mapping of the electrical activity and networking relationships within the brain.
Pharmacogenetics is the study of how an individual’s DNA affects their response to medication. Genomic mapping informs issues of dosing, efficacy, medication intolerance and drug interactions. Findings are matched with databases that guide specific prescriptive choices.
ReCognition is Yellowbrick’s cognitive enhancement “Brain Gym” offering online training programs strengthening cognitive processes such as attention, concentration, working memory and problem solving which are crucial to effective role performance.
Neuro-cognitive testing examines discrete cognitive and mental processing functions.
Expert clinical judgment in applying these neuroscience techniques may reveal previously undetected diagnosis or impairments, as well as “signature treatment response patterns” which inform therapeutic strategy.
Yellowbrick employs multiple neuro-modulation techniques including Deep Transcranial Magnetic Stimulation (dTMS) as an FDA approved treatment for depression which has not responded to medication. Neurofeedback allows for redirecting de-regulated neural networks to reduce anxiety, cognitive impairment and impulsivity. Direct current stimulation relieves anxiety and improves sleep by inducing an alpha brain state. Each of these interventions is often highly effective quickly, non-invasive and without adverse effects.
At Yellowbrick, emerging adults find their way home.
For more information, please contact Yellowbrick at 866.364.2300.